15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells by 源�寃쏀솚
INTRODUCTION
The microaerophilic bacterium, Helicobacter pylori (H.
pylori), plays an important role in the pathogenesis of chronic
gastritis, peptic ulcer, gastric adenocarcinoma, and gastric
mucosa-associated lymphoid tissue lymphoma (1-5). The
epithelial cytokine/chemokine response is particularly important
in the early stages of H. pylori-induced inflammation. RANTES
(short for "regulated upon activation, normal T cell expressed
and secreted") is a potent chemotactic agent for T lymphocytes
and monocytes (6) and expressed in fibroblasts, T cells,
monocytes, endothelial cells, and epithelial cells after
inflammatory stimuli. Therefore, RANTES may contribute to
the infiltration of inflammatory cells into gastric tissues infected
with H. pylori. Indeed, H. pylori induced the expression of
RANTES in gastric epithelial cells (7), which may activate
infiltrating inflammatory cells such as lymphocytes into the
infected tissues. Reactive oxygen species (ROS) are produced in
the activated inflammatory cells of the infected tissues (8) and
gastric epithelial cells infected with H. pylori (9-11).
One of the main sources of ROS in phagocytic and non-
phagocytic cells is NADPH oxidase. Activation of NADPH
oxidase requires the assembly of membrane-integrated
cytochrome b558 (a heterodimer formed by gp91phox and p22phox)
with cytosolic components p47 phox, p67 phox, and the small
GTPase Rac (12). During the activation of NADPH oxidase, Rac
translocates to the membrane and GTP-bound Rac directly
interacts with p67phox and p47phox (13, 14). We recently found that
H. pylori induces translocation of HSP90β from cytosol to
membrane (15). In the membrane, HSP90β interacts with Rac1,
which activates NADPH oxidase to produce ROS in H. pylori-
infected gastric epithelial cells. Therefore, NADPH oxidase may
be an upstream signaling mediator in H. pylori-induced gastric
inflammation.
Jak/Stat (Januas kinase/signal transducers and activators of
transcription) signaling cascade functions as one of the major
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Peroxisome proliferators-activated receptor-γ (PPAR-γ) is a ligand-activated transcription factor. 15 deoxy-12,14 prostaglandin
J2 (15d-PGJ2) is a potent PPAR-γ ligand and acts as an anti-inflammatory agent via PPAR-γ-dependent and independent
mechanisms. Helicobacter pylori (H. pylori) induces gastric inflammation by inducing the activation of oxidant-sensitive
transcription factor NF-κB and cytokine expression in gastric epithelial cells. Since 15d-PGJ2 inhibits NF-κB activation in
various cells, it may suppress H. pylori-induced inflammatory signaling and cytokine expression in gastric epithelial cells.
The present study aims to determined the effect of 15d-PGJ2 on the activation of inflammatory mediators Jak/Stat (Janus
kinase/signal transducers and activators of transcription) and induction of cytokine RANTES in H. pylori-infected gastric
epithelial AGS cells. Since NADPH oxidase is a candidate for the production of reactive oxygen species in H. pylori-infected
gastric epithelial cells, we determined the effect of 15d-PGJ2 on the activation of NADPH oxdase. AGS cells were cultured
in the presence of H. pylori treated with or without 15d-PGJ2. The activations of NADPH oxidase and Jak1/Stat3, the levels
of H2O2 and RANTES in the medium, and DNA binding activity of Stat3 were assessed. A Jak/Stat3 specific inhibitor AG490
and an inhibitor of NADPH oxidase diphenyleneiodonium (DPI) were treated to determine the direct involvement of Jak/Stat
and NADPH oxidase on the production of H2O2 and RANTES in H. pylori-infected cells. H. pylori induced the production
of H2O2 and RANTES as well as the activations of NADPH oxidase and Jak1/Stat3, which were inhibited by the treatment
of 15d-PGJ2. DPI suppressed H. pylori-induced alterations similar to 15d-PGJ2. However, AG490 had no effect on NADPH
oxidase activation, but reduced the level of RANTES in the medium released from H. pylori-infected cells. Conclusion:
NADPH oxidase activation is an upstream signaling of Jak1/Stat3 activation and induction of RANTES in H. pylori-infected
AGS cells. 15d-PGJ2, inhibits the activations of NADPH oxidase and Jak1/Stat3 and RANTES expression, suggesting that
15d-PGJ2 may be beneficial for the treatment of H. pylori-induced gastric inflammation.
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immune and cytokine signals (16, 17). The binding of
inflammatory ligand such as cytokine to its receptor induces the
assembly of an active receptor associated Jaks (Jak1, Jak2, Jak3,
and TYK2). Phosphorylated Jaks lead to the activation of
neighboring Jaks, receptor subunits, and several other substrates.
Phosphorylation of Jak provides the docking sites for Stats,
which in turn become phosphorylated on tyrosine and serine
residues; the phosphorylations of both amino acid species are
required for full Stat activity. Phosphorylated Stats are released
from the receptor complex and form dimmers. These dimmers
translocate to the nucleus where they directly bind to the
promoter region of specific target genes, thus regulating
transcription of these genes involved in immune responses (18-
20). Therefore, it is possible that H. pylori-stimulated
inflammatory signaling includes Jak/Stat activation. However,
the role of Jak/Stat on H. pylori infection has not been
investigated yet.
15deoxy-∆12,14-prostaglandin J2 (15d-PGJ2) is a natural
ligand that activates the peroxisome proliferators-activated
receptor-γ (PPAR-γ), a member of nuclear receptor family. 15d-
PGJ2 stimulates transcription of target genes via PPAR-γ-
dependent mechanism (21). It exerts anti-inflammatory activities
in macrophages and endothelial cells via PPAR-γ- dependent and
independent mechanisms (22-25). The recent studies
demonstrated that 15d-PGJ2 has anti-inflammatory action by
inhibiting the activation of NF-κB (26-28) and mitogen-
activated protein kinases (MAPK) (28), and the induction of
cytokines and chemokines (28, 29). 15d-PGJ2 inhibited IFNγ-
induced Jak/Stat signaling pathway independent of PPAR-γ (30).
15d-PGJ2 and other PPAR-γ ligand ciglitazone inhibited O2-
production by suppressing the expression of NADPH oxidase, a
major source of O2- in vascular endothelial cells (31).
Previously, we found that H. pylori stimulates the production of
ROS (9-11) and induces the expression of cytokines by
activating NF-κB and MAPK in gastric epithelial cells (32-34).
Therefore, 15d-PGJ2 may inhibit NADPH oxidase activation and
thus, suppress ROS production and inflammatory signaling in H.
pylori-infected gastric epithelial cells. Recently it has been
reported that H. pylori induced nuclear translocation of PPAR-γ
in gastric epithelial cells (35).
In the present study, we determined whether 15d-PGJ2
inhibits the activation of NADPH oxidase and inflammatory
mediators Jak/Stat and induction of RANTES in H. pylori-
infected gastric epithelial AGS cells. A Jak/Stat3 specific
inhibitor AG490 and an inhibitor of NADPH oxidase
diphenyleneiodonium (DPI) were treated to the cells for
investigating the direct involvement of Jak/Stat and NADPH
oxidase on the production of H2O2 and RANTES in H. pylori-
infected cells.
MATERIALS AND METHODS
Reagents
Reagents for nitrocellulose membranes were obtained from
Amersham Inc. (Arlington Heights IL, USA). Anti-
phosphotyrosine-Stat3 (Tyr705) antibody was purchased from
Cell Signaling Technology Inc. (Beverly, MA, USA). Polyclonal
anti-Stat3 antibody was purchased from Upstate (Charlottesville,
VA, USA). Antibodies against phospho-Jak1, Jak1, p47phox,
p67phox, actin and anti-rabbit and anti-goat secondary antibodies
were all purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). 15-deoxy-∆12,14-proglastandin J2 (15d-PGJ2, PPAR-γ
ligand), Tyrphostin AG490 (Jak/Stat3 specific inhibitor), and
diphenyleneiodonium (DPI, NADPH oxidase inhibitor) were
purchased from Calbiochem (La Jolla, CA, USA). 15d-PGJ2,
AG490 and DPI were dissolved in dimethysulfoxide (DMSO)
and pretreated to AGS cells at final concentrations of 10 µM
(15d-PGJ2), 40 µM (AG490), and 10 µM (DPI) 2 hours prior to
H. pylori treatment. Xylenol orange and β-nicotinamide adenine
dinucleotide phosphate reduced form (β-NADPH) were
obtained from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture
Human gastric epithelial AGS cells (gastric
adenocarcinoma, ATCC CRL 1739) were obtained from the
American Type Culture Collection (Manassas, VA, USA) and
grown until 70-80% confluent in RPMI-1640 medium (pH 7.4;
Sigma-Aldrich) supplemented with 10% fetal bovine serum, 4
mM glutamine (GIBCO-BRL, Grand Island, NY, USA) and
antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin).
The cells were used for the experiments 20 hours after seeding
at 37°C in a humidified atmosphere of 95% air-5% CO2.
Helicobacter pylori culture and infection
An H. pylori strain used in the present study is HP99 which
was isolated form Korean patients and identified as cagA+,
vacA+ strain (34). HP99 is kindly provided from Dr. H.C. Jung
(Seoul National University College of Medicine, Seoul, Korea).
These bacteria were inoculated onto chocolate agar plates
(Becton Dickinson Microbiology Systems, Cockeysville, MD,
USA) at 37°C under microaerophilic conditions using an
anaerobic chamber (BBL Campy Pouch® System, Becton
Dickinson Microbiology Systems). H. pylori suspended in
antibiotic-free cell culture medium were added to AGS cells at a
bacterium/cell ratio of 300:1, based on the previous studies (9,
11, 36).
Determination of H2O2 in the medium
The cells (3x105/ml) were cultured in the presence or
absence of H. pylori for 15, 30, and 60 min. Levels of H2O2 in
the medium were determined by xylenol orange (XO) assay
(37). At each time point, the medium was collected and
centrifuged to eliminate bacteria and cell debris. 20 µl of
supernatant was added to 200 µl of XO mixture (containing 125
µM XO, 100 mM D-sorbitol, 250 µM FeSO4, 250 µM
(NH4)2SO4, 25 mM H2SO4). Sample/XO mixture was reacted for
30 min at room temperature. Absorbance at 560 nm (A560) of
sample/XO mixture was measured against a blank prepared with
20 µl fresh medium containing 200 µl of XO mixture. A standard
curve was prepared with different concentrations of H2O2. For
investigating the effects of 15d-PGJ2, AG490, and DPI on H.
pylori-induced increase in H2O2 production, the cells were
treated with 15d-PGJ2, AG490, and DPI for 2 hours, and
cultured in the presence of H. pylori for 30 min.
Preparation of extracts
The cells (3.5x106/ml) were cultured in the presence or absence
of H. pylori for 15, 30, 60 (for activity and activation of NADPH
oxidase), or 120 min (for Jak/Stat activation). The cells were rinsed
with ice-cold PBS, harvested by scraping into PBS and pelleted by
centrifugation at 1,500 rpm for 5 min. The cells were suspended
with lysis buffer containing 10 mM Tris, pH 7.4, 15 mM NaCl, 1%
NP-40, complete (protease inhibitor complex, Roche, Mannheim,
Germany), extracted by drawing the cells through a 1-ml syringe
with several rapid strokes, left on ice for 30 min, and centrifuged at
13,000 rpm for 10 min. The supernatant was collected and used as
a whole cell extract. To prepare the cytosolic and membrane
fractions, the supernatant was separated further by centrifugation at
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100,000 g for 1 hour. The membrane fraction was obtained by
suspending the pellet with lysis buffer containing 50 mM HEPES,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 10% glycerol. The
supernatant was used as the cytosolic fraction. The protein
concentration was determined by the Bradford method (38) using
Bio-Rad protein assay solution (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). For determining the effects of 15d-PGJ2,
AG490, and DPI on H. pylori-induced increase in NADPH oxidase
activity, activation of NADPH oxidase, and Jak/Stat activation, the
cells were treated with 15d-PGJ2, AG490, and DPI for 2 hours and
cultured in the presence of H. pylori for 15 min (for activity and
activation of NADPH oxidase) or 30 min (for Jak/Stat activation).
Measurement of NADPH oxidase activity
NADPH oxidase activity was measured by lucigenin assay.
The membrane and cytosolic fractions were prepared as
described previously. The assay was performed in 50 mM Tris-
Mes buffer, pH 7.0, containing 2 mM KCN, 10 µM lucigenin
and 100 µM NADPH as the substrate. The reaction was started
by addition of membrane fractions containing 10 µg proteins.
The photon emission was measured every 15 s for 5 min in a
microtiterplate luminometer (MicroLumat LB 96V luminometer,
Berthold, NH, USA). NADPH oxidase activity was also
monitored by addition of cytosolic fractions to the reaction
mixture as a negative control. As a reference experiment, to
determine the possible artifacts by lucigenin concentration, the
membrane fractions were prepared from the cells cultured in the
absence of H. pylori. ROS production was monitored by addition
of membrane fraction to a reaction mixture containing NADPH
and the concentration of 10 µM lucigenin. The photon emission
was measured every 15 s for 5 min in a microtiterplate
luminometer.
Western blot analysis
The proteins of whole cell extract, cytosolic fraction, and
membrane fraction were loaded, separated by 8-12% SDS-
polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membranes by electroblotting. After blocking of
nonspecific binding with 5% nonfat dry milk in TBS-T (Tris-
buffered saline and 0.15% Tween 20) for 2 hours at room
temperature, the membranes were probed with primary antibody
(phospho-Jak1, Jak1, phospho-Stat3, Stat3, p47phox, and p67phox)
at 4°C overnight. Primary antibodies were detected using
horseradish peroxidase-conjugated secondary antibodies (anti-
goat or anti-rabbit), respectively, and visualized by the ECL
detection system (Santa Cruz Biotechnology) according to the
manufacturer's instruction. Actin served as a loading control.
Nuclear extracts preparation and electrophoretic mobility shift
assay (EMSA) for Stat3-DNA binding activity
The cells (3.5x106/ml) were treated with or without 15d-
PGJ2, AG490, and DPI for 2 hours and cultured in the presence
of H. pylori for 30 min. Nuclear extracts were prepared as
described previously (33). Stat3 gel shift oligonucleotide (5'-
GATCCTTCTGGGAATTCCTAGATC-3') from Santa Cruz
Biotechnology were labeled with [32P] dATP (Amersham Inc.)
using T4 polynucleotide kinase (GIBCO-BRL). End-labeled
probe was purified from unincorporated [32P] dATP using a
purification column (Bio-Rad Laboratories) and recovered in
Tris-EDTA buffer (TE). Nuclear extracts (3 µg) were pre-
incubated in buffer containing 12% glycerol, 12 mM HEPES,
pH 7.9, 4 mM Tris-HCl, pH 7.9, 1 mM EDTA, 1 mM DTT, 25
mM KCl, 5 mM MgCl2, 0.04 µg/ml poly [dI-dC] (Amersham
Inc.), 0.4 mM PMSF, and TE. The labeled probe was added and
samples were reacted on room temperature for 30 min. Samples
were loaded, separated by electrophoresis on a non-denaturing
5% polyacrylamide gel at 200 mM using 0.5X TBE buffer. The
gels were dried at 80°C for 30 min and exposed to the
radiography film for 6-18 hours at -70°C with intensifying
screens (39).
Determination of RANTES in the medium
The cells (5x105/ml) were cultured in the presence or
absence of H. pylori for 4, 8, 12, and 24 hours. The levels of
RANTES in the medium were determined by enzyme-linked
immunosorbent assay (ELISA, Biosource, Camarillo, CA,
USA). For determining the effects of 15d-PGJ2, AG490, and DPI
on H. pylori-induced production of RANTES, the cells were
treated with 15d-PGJ2, AG490, and DPI for 2 hours and cultured
in the presence of H. pylori for 4 hours.
Statistical analysis
The statistical differences were determined using one-way
ANOVA by Newman-Keul's test. All values are expressed as a
mean S.E. of four different experiments. A value of p<0.05 was
considered statistically significant.
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Fig. 1. H2O2 levels in the medium released from H. pylori-
infected AGS cells. (A) The levels of H2O2 in the medium were
determined by xylenol orange assay and expressed as nmole/ml.
The cells were cultured in the presence or absence of H. pylori
(bacterium/cell ratio of 300:1) for 15, 30, and 60 min. (B) For the
effects of 15d-PGJ2, AG490, and DPI on H. pylori-induced H2O2
production, the cells were treated with 15d-PGJ2 (10 µM),
AG490 (40 µM), and DPI (10 µM) for 2 hours, and cultured in
the presence of H. pylori for 30 min. Values are means ±S.E.
*P<0.05 compared with corresponding none (the cells culture in
the absence of H. pylori), +P<0.05 compared with H. pylori
control (without treatment 15d-PGJ2, DPI, and AG490).
RESULTS
H2O2 levels in the medium released from H. pylori-infected
AGS cells
H2O2 levels in the medium released from H. pylori-infected
AGS cells were determined during 60 min-culture period (Fig.
1A). Without H. pylori, the cells produced very low levels of H2O2
at each time point. With H. pylori, H2O2 levels in the medium
increased from 15 min which continued up to 60 min. Therefore,
to determine the effect of 15d-PGJ2, DPI, and AG490 on H. pylori-
induced H2O2 production, the cells were treated with 15d-PGJ2,
AG490, and DPI for 2 hours and cultured in the presence of H.
pylori for 30 min (Fig. 1B). Both 15d-PGJ2 and DPI, an NADPH
oxidase inhibitor, inhibited H. pylori-induced increase in H2O2
levels, but AG490, a Jak/Stat3 inhibitor, has no effect on H2O2
production in H. pylori-infected AGS cells. H2O2 levels in the
medium released from H. pylori-uninfected AGS cells (None)
were not changed by treatment of 15d-PGJ2, DPI, and AG490.
NADPH oxidase activity of H. pylori-infected AGS cells
By monitoring ROS production with lucigenin luminescence
from the membrane fractions of the cells infected with H. pylori,
NADPH oxidase activity of H. pylori-infected cells was
determined (Fig. 2). The cells have a relatively low activity of
NADPH oxidase at the start of the experiment (0 min). H. pylori
substantially stimulated NADPH oxidase activity of the cells
from 15 min infection of H. pylori, which continued up to 60 min
(Fig. 2A). To determine the effect of 15d-PGJ2, DPI, and AG490
on H. pylori-induced increase in NADPH oxidase, the cells were
treated with 15d-PGJ2, AG490, and DPI for 2 hours and cultured
in the presence of H. pylori for 15 min (Fig. 2B). H. pylori-
induced increase in NADPH oxidase activity was significantly
suppressed by 15d-PGJ2. Similar effect was shown by DPI.
However, AG490 had no effect on H. pylori-induced increase in
NADPH oxidase activity, which was similar to its effect on H.
pylori-induced increase in H2O2 levels of AGS cells (Fig. 1B).
Therefore, NADPH oxidase may be an upstream signaling for
Jak/Stat3 activation in H. pylori-infected AGS cells.
NADPH oxidase activation of Helicobacter pylori-infected
AGS cells
For NADPH oxidase activation, the translocation of cytosolic
subunits p47phox and p67phox to the membrane is required. As
shown in Fig. 3A, p47phox and p67phox in cytosol were translocated
to membrane at 15 min after H. pylori infection. After 15 min of
infection with H. pylori, p67phox and p47phox in the membrane
tended to return to the cytosol. Actin as a loading control was not
changed by H. pylori (Fig. 3A). To determine the effect of 15d-
PGJ2, DPI, and AG490 on H. pylori-induced activation of
NADPH oxidase, the cells were treated with 15d-PGJ2, AG490,
and DPI for 2 hours and cultured in the presence of H. pylori for
15 min (Fig. 3B). H. pylori-induced translocation of cytosolic
subunits, p47phox and p67phox, to membrane was inhibited by 15d-
PGJ2 and DPI. However, AG490 had no effect on H. pylori-
induced activation of NADPH in AGS cells.
Jak1/Stat3 activation and Jak3-DNA binding activity of
Helicobacter pylori-infected AGS cells
The activation of Jak1/Stat3 of H. pylori-infected cells
was determined by phosphorylation of Jak1 and Stat3 of the
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Fig. 2. NADPH oxidase activity of H. pylori-infected AGS cells.
(A) The NADPH oxidase activities were determined by
lucigenin assay. The cells were cultured in the presence or
absence of H. pylori (bacterium/cell ratio of 300:1) for 15, 30,
and 60 min. Membrane fractions of H. pylori-infected AGS cells
were added to 10 µM lucigenin to determine NADPH oxidase
activity and cytosolic fractions were used for the negative
control. NADPH oxidase activity was expressed as RLU/mg
protein. (B) To determine the effect of 15d-PGJ2, DPI, and
AG490 on H. pylori-induced increase in NADPH oxidase
activity, the cells were treated with 15d-PGJ2 (10 µM), AG490
(40 µM), and DPI (10 µM) for 2 hours and cultured in the
presence of H. pylori for 15 min. Values are means ±S.E.
*P<0.05 compared with 0 min (A) or none (B, the cells culture
in the absence of H. pylori). +P<0.05 compared with H. pylori
control (without treatment of 15d-PGJ2, DPI, and AG490).
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Fig. 4. Time-dependent activation of Jak1/Stat3 of H. pylori-
infected AGS cells. The cells were cultured in the presence or
absence of H. pylori (bacterium/cell ratio of 300:1) for 15, 30,
60, and 120 min. Whole cell extracts were prepared from H.
pylori-infected cells. Phospho-specific and total forms of Jak1
and Stat3 were determined by Western blot analysis.
cells. Phospho-specific forms of Jak1 and Stat3 were observed
at 15 min of H. pylori infection, which increased until 120 min
(Fig. 4) while total forms of Jak1 and Stat3 were not changed
by H. pylori. To determine the effect of 15d-PGJ2, DPI, and
AG490 on H. pylori-induced activation of Jak1/Stat3 and
increase in Jak3-DNA binding activity of AGS cells, the cells
were treated with 15d-PGJ2, AG490, and DPI for 2 hours and
cultured in the presence of H. pylori for 30 min (Fig. 5). 15d-
PGJ2, DPI, and AG490 inhibited H. pylori-induced
phosphorylation of Jak/Stat3 (Fig. 5A) and Stat3-DNA
binding activity (Fig. 5B) of AGS cells. Since DPI, an
inhibitor of NADPH oxidase, suppressed the activation of
Jak1/Stat3 similar to AG490, a Jak/Stat inhibitor, NADPH
oxidase may regulate the activation of Jak1/Sat3 signaling in
H. pylori-infected AGS cells. Taken together, 15d-PGJ2
suppresses the activation of NADPH oxidase and the
production of H2O2, which activates Jak1/Stat3 in H. pylori-
infected gastric epithelial cells.
RANTES levels in the medium released from Helicobacter pylori-
infected AGS cells
H. pylori increased the levels of RANTES in the medium
time-dependently until 24 hours (Fig. 6A). To investigate the
effect of 15d-PGJ2, DPI, and AG490 on H. pylori-induced
increase in RANTES in the medium released from AGS cells, the
cells were treated with 15d-PGJ2, AG490, and DPI for 2 hours
and cultured in the presence of H. pylori for 4 hours (Fig. 6B).
15d-PGJ2, AG490, and DPI significantly suppressed H. pylori-
induced increase in RANTES in the medium released from AGS
cells. The results show the involvement of NADP oxidase and
Jak1/Stat3 in RANTES production in H. pylori-infected AGS
cells. Without H. pylori, 15d-PGJ2, AG490, and DPI did not
affect the production of RANTES in AGS cells.
DISCUSSION
H. pylori-induced inflammatory signalings have been
focused on the activation of NF-κB and AP-1 and IL-8
expression in gastric epithelial cells (9, 10, 32-34). In the present
study, we found that Jak/Stat inflammatory signaling may
mediate the expression of cytokines such as RANTES in H.
pylori-infected cells. Even though Jak/Stat signaling has been
widely studied on nervous system (40), the role of Jak/Stat
activation in gastric diseases associated with H. pylori infection
has not been well established. In the present study, we suggest
that Jak/Stat activation may have a critical role in H. pylori-
induced gastric inflammation by inducing cytokines including
RANTES in gastric epithelial cells.
Previously, we demonstrated that H. pylori-induced
production of ROS mediates the activation of NF-κB and AP-1
and induction of IL-8 in gastric epithelial cells (10). In the
present study, H. pylori induced increase in NADPH oxidase
activity and translocation of NADPH oxidase cytosolic subunits,
p67phox and p47phox, to membrane in gastric epithelial AGS cells.
H. pylori-induced activation of NADPH oxidase and H2O2
production were inhibited by DPI, an inhibitor of NADPH
oxidase. The results suggest that the source of ROS is NADPH
oxidase in H. pylori-infected gastric epithelial cells. The present
results were supported by our previous study showing that
interaction of HSP90 with Rac1 activates NADPH oxidase in the
membrane of H. pylori-infected gastric epithelial cells (15).
The activation of Jak1 and Stat3 plays an important role in
the initiation of inflammation through the expression of
inflammatory genes such as chemokines, cytokines, and
adhesion molecules. All of these products initiate recruitment
and activation of inflammatory cells and induction of
inflammation. In the present study, AG490, an inhibitor of
Jak/Stat3, did not inhibit H. pylori-induced H2O2 production,
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Fig. 3. NADPH oxidase activation of H. pylori-
infected AGS cells. (A) The cells were cultured in
the presence or absence of H. pylori (bacterium/cell
ratio of 300:1) for 15, 30, and 60 min. Protein levels
of p47phox and p67phox in cytosolic and membrane
fractions were determined by Western blot analysis.
Actin served as a loading control. (B) To determine
the effect of 15d-PGJ2, DPI, and AG490 on H.
pylori-induced activation of NADPH oxidase, the
cells were treated with 15d-PGJ2 (10 µM), AG490
(40 µM), and DPI (10 µM) for 2 hours and cultured
in the presence of H. pylori for 15 min.
NADPH oxidase activity, and translocation of p67phox and p47phox
to the membrane, which was induced by H. pylori. The results
demonstrate that Jak1 and Stat3 activation is the downstream
signaling of NADPH oxidase which is activated by H. pylori in
gastric epithelial cells.
Regarding the uptake of 15d-PGJ2 into the cells,
prostaglandins transported into the cells by a carrier-mediated
active transport system (40-42). In the cells, 15d-PGJ2 binds to
PPAR-γ, but in some cases, it induces cellular responses devoid
of PPAR-γ (43). Some of these effects have been reported to be
mediated through covalent interaction of 15d-PGJ2 with
intracellular proteins such as IκB kinase (44) and inhibit
extracellular signal-regulated kinase (ERK) signaling pathway
(45). Novel finding of the present study is that the 15d-PGJ2
inhibits the activation of NADPH oxidase, which may be the
starting point of H. pylori -induced inflammation.
In the studies of PPAR-γ ligands on gastric inflammation, the
protective effect of PPAR-γ ligands, pioglitazone or 15d-PGJ2, on
gastric ischemia-reperfusion injury was reported in rats treated
ischemia-reperfusion via up-regulation of heat shock proteins and
endoplasmic reticulum-related proteins (46) as well as inhibiting
the induction of cyclooxygenase-2 (47). In addition, pioglitazone
accelerates the healing of preexisting gastric ulcers of rats due to
the anti-inflammatory action including suppression of
interleukin-1β, TNF-α, cyclooxygenase-2 and iNOS and
overexpression of HSP70 (48). PPAR-γ ligands inhibit
inflammatory gene transcription by inhibiting NF-κB activation
by PPAR-γ-dependent and independent mechanisms (49-51). A
PPAR-γ antagonist GW9662 reversed protective effect of 15d-
PGJ2 on acute gastric mucosal injury, suggesting that 15d-PGJ2
inhibits severity of gastric damage and expression of
inflammatory cytokines such as TNF-α through PPAR-γ-
dependent mechanisms (52). Slomiany have demonstrated that H.
pylori lipopolysaccharide- (LPS-) elicited mucosal inflammatory
responses were accompanied by a massive epithelial cell
apoptosis, upregulation of iNOS, and COX-2 expression, and
PPAR. PPAR-γ ligand ciglitazone suppresses these gastric
mucosal inflammatory responses and may provide therapeutic
benefits such as the amelioration of inflammation associated with
H. pylori infection (53).
In the present study, we used a Jak/Stat3 specific inhibitor
AG490 and an inhibitor of NADPH oxidase diphenyleneiodonium
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Fig. 5. The effects of 15d-PGJ2, DPI, and AG490 on Jak1/Stat3
activation and Stat3-DNA binding activity of H. pylori-infected
AGS cells. (A) The cells were treated with 15d-PGJ2 (10 µM),
DPI (10 µM), and AG490 (40 µM) for 2 hours and cultured in
the presence of H. pylori (bacterium/cell ratio of 300:1) for 30
min. Phospho-specific and total forms of Jak1 and Stat3 in whole
cell extracts were determined by Western blot analysis. (B)
DNA-binding activity of Stat3 in nuclear extracts was
determined by EMSA.
0
10
20
30
40
50
60
0 4 8 12 24
R
A
N
TE
S 
(p
g/
m
l) None
HP99 
(h)
A
B
0
2
4
6
8
10
12
14
R
A
N
TE
S 
(p
g/
m
l) None
HP99
Con        15d-PGJ2 AG490           DPI
*
*
*
*
*
+ + +
None
H. pylori
None
H. pylori
Fig. 6. RANTES levels in the medium released from H pylori-
infected AGS cells. (A) The level of RANTES in the medium was
determined by ELISA and expressed as pg/ml. The cells were
cultured in the presence or absence of H. pylori (bacterium/cell
ratio of 300:1) for 4, 8, 12, and 24 hours. (B) To determine the
effect of 15d-PGJ2, DPI, and AG490 on H. pylori-induced
production of RANTES, the cells were treated with 15d-PGJ2 (10
µM), AG490 (40 µM), and DPI (10 µM) for 2 hours and cultured
in the presence of H. pylori for 4 hours. Values are means ±S.E.
*P<0.05 compared with the corresponding none (the cells culture
in the absence of H. pylori). +P<0.05 compared with H. pylori
control (without treatment of 15d-PGJ2, DPI, and AG490).
(DPI) to determine the direct involvement of Jak/Stat and NADPH
oxidase on the production of H2O2 and RANTES in H. pylori-
infected cells. We found that DPI suppressed H. pylori-induced
alterations similar to 15d-PGJ2. However, AG490 had no effect on
NADPH oxidase activation, but reduced the level of RANTES in
the medium released from H. pylori-infected cells. The results
show that NADPH oxidase activation is an upstream signaling of
Jak1/Stat3 activation in H. pylori-infected AGS cells. ROS
produced by NADPH oxidase activate inflammatory signaling
including Jak1/Stat3 which induces the expression of RANTES in
H. pylori-infected AGS cells. 15d-PGJ2 inhibits the activations of
NADPH oxidase and Jak1/Stat3 and RANTES expression,
suggesting that 15d-PGJ2 may be beneficial for the treatment of H.
pylori-induced gastric inflammation. However, we could not
conclude whether the inhibitory effect of 15d-PGJ2 on the
activations of NADPH oxidase and Jak1/Stat3 and induction of
RANTES in H. pylori-infected gastric epithelial cells is through
PPAR-γ activation or not. Further study should be performed
using A PPAR-γ antagonist to determine the involvement of
PPAR-γ in the effect of 15d-PGJ2 on the protection of gastric
epithelial cells from H. pylori infection.
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